Therefore, this study aimed to investigate the correlation of genetic polymorphisms of SLCO1B3 and SLCO1B1 to the efficacy and safety of MTX in patients with RA in Saudi Arabia. This evidence concerns the gene SLCO1B3 and rheumatoid arthritis.